Many fixed-dose drug combinations in India lack central regulatory approval

Fixed-dose drug combinations (FDCs) which have not received central regulatory approval are sold in substantial numbers in India -- despite concerns over the safety and efficacy of these combinations -- according to new research. FDCs include two or more active pharmaceutical ingredients combined in a single dosage form. They are used as effective treatments for many conditions, including tuberculosis, Parkinson's disease, HIV and malaria.
Source :      2015/6/27 08:26

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.